2024 Napa Valley Lung Cancer Conference

This CME-accredited activity “2024 Napa Valley Lung Cancer Conference” features leading experts in thoracic malignancies who will provide a comprehensive overview of current and emerging strategies for management of lung cancer (NSCLC, SCLC). The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with lung cancer. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in molecular testing and targeted-therapies for thoracic oncology. Expert faculty will aim to place the role of diagnostics, biomarkers and different therapeutic agents in clinical context and discuss how to utilize these tests and therapies to effectively contribute to patient care.